Literature DB >> 28467941

Metabolic Surgery in a Pill.

Alexander D Miras1, Carel W le Roux2.   

Abstract

Bariatric surgery has evolved from a very effective treatment of weight to a treatment of "metabolism" and end-organ damage. Even though surgery was designed with the aim of causing mechanical restriction and calorie malabsorption, mechanistic work in humans and rodents over the last 10 years or so has informed us that this could not be further from the truth. Dietary, pharmacological, and medical device interventions for weight loss and metabolic control have also evolved rapidly only very recently. In this Crosstalk we discuss how close we are to harnessing the clinical efficacy of surgery through a metabolic "polypill."
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28467941     DOI: 10.1016/j.cmet.2017.04.028

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  4 in total

Review 1.  [Bariatric surgery: Expectations and therapeutic goals-a contradiction?]

Authors:  I Hering; C Stier; F Seyfried
Journal:  Chirurg       Date:  2018-08       Impact factor: 0.955

2.  Intestinal bitter taste receptor activation alters hormone secretion and imparts metabolic benefits.

Authors:  Bernard P Kok; Andrea Galmozzi; Nicole K Littlejohn; Verena Albert; Cristina Godio; Woojoo Kim; Sean M Kim; Jeffrey S Bland; Neile Grayson; Mingliang Fang; Wolfgang Meyerhof; Gary Siuzdak; Supriya Srinivasan; Maik Behrens; Enrique Saez
Journal:  Mol Metab       Date:  2018-08-04       Impact factor: 7.422

3.  Therapeutic reduction of lysophospholipids in the digestive tract recapitulates the metabolic benefits of bariatric surgery and promotes diabetes remission.

Authors:  James G Cash; Eddy Konaniah; Narasimha Hegde; David G Kuhel; Miki Watanabe; Lindsey Romick-Rosendale; David Y Hui
Journal:  Mol Metab       Date:  2018-07-26       Impact factor: 7.422

4.  Non-insulin determinant pathways maintain glucose homeostasis upon metabolic surgery.

Authors:  Zongshi Lu; Xiao Wei; Fang Sun; Hexuan Zhang; Peng Gao; Yunfei Pu; Anlong Wang; Jing Chen; Weidong Tong; Qiang Li; Xunmei Zhou; Zhencheng Yan; Hongting Zheng; Gangyi Yang; Yu Huang; Daoyan Liu; Zhiming Zhu
Journal:  Cell Discov       Date:  2018-09-25       Impact factor: 10.849

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.